BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26617845)

  • 21. ABCG2-meditated multidrug resistance and tumor-initiating capacity of side population cells from colon cancer.
    Xie ZY; Lv K; Xiong Y; Guo WH
    Oncol Res Treat; 2014; 37(11):666-8, 670-2. PubMed ID: 25427584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma.
    Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS
    Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma.
    Nakai E; Park K; Yawata T; Chihara T; Kumazawa A; Nakabayashi H; Shimizu K
    Cancer Invest; 2009 Nov; 27(9):901-8. PubMed ID: 19832037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
    Srivastava VK; Nalbantoglu J
    Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The CD133+ subpopulation of the SW982 human synovial sarcoma cell line exhibits cancer stem-like characteristics.
    Liu A; Feng B; Gu W; Cheng X; Tong T; Zhang H; Hu Y
    Int J Oncol; 2013 Apr; 42(4):1399-407. PubMed ID: 23416969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.
    Zhao Y; Zhao L; Ischenko I; Bao Q; Schwarz B; Nieß H; Wang Y; Renner A; Mysliwietz J; Jauch KW; Nelson PJ; Ellwart JW; Bruns CJ; Camaj P
    Target Oncol; 2015 Dec; 10(4):535-48. PubMed ID: 25639539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of spheres derived from canine mammary gland adenocarcinoma cell lines.
    Michishita M; Akiyoshi R; Yoshimura H; Katsumoto T; Ichikawa H; Ohkusu-Tsukada K; Nakagawa T; Sasaki N; Takahashi K
    Res Vet Sci; 2011 Oct; 91(2):254-60. PubMed ID: 21190702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
    Zhang QH; Dou HT; Xu P; Zhuang SC; Liu PS
    Drug Res (Stuttg); 2015 Mar; 65(3):153-7. PubMed ID: 25504004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.
    Banerjee S; Nomura A; Sangwan V; Chugh R; Dudeja V; Vickers SM; Saluja A
    Clin Cancer Res; 2014 May; 20(9):2388-99. PubMed ID: 24634377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling.
    Annabi B; Lachambre MP; Plouffe K; Sartelet H; Béliveau R
    Mol Carcinog; 2009 Oct; 48(10):910-9. PubMed ID: 19326372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary study of side population cells in human gastric cancer cell line HGC-27.
    Gao G; Sun Z; Wenyong L; Dongxia Y; Zhao R; Zhang X
    Ann Transplant; 2015 Mar; 20():147-53. PubMed ID: 25773762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
    Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
    Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells.
    Yanamoto S; Kawasaki G; Yamada S; Yoshitomi I; Kawano T; Yonezawa H; Rokutanda S; Naruse T; Umeda M
    Oral Oncol; 2011 Sep; 47(9):855-60. PubMed ID: 21757396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
    Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
    Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells.
    Jin F; Zhao L; Guo YJ; Zhao WJ; Zhang H; Wang HT; Shao T; Zhang SL; Wei YJ; Feng J; Jiang XB; Zhao HY
    Brain Res; 2010 Jun; 1336():103-11. PubMed ID: 20388502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of CD133(+) human colon cancer SW620 cells.
    Kawamoto H; Yuasa T; Kubota Y; Seita M; Sasamoto H; Shahid JM; Hayashi T; Nakahara H; Hassan R; Iwamuro M; Kondo E; Nakaji S; Tanaka N; Kobayashi N
    Cell Transplant; 2010; 19(6):857-64. PubMed ID: 20587144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia induces tumor aggressiveness and the expansion of CD133-positive cells in a hypoxia-inducible factor-1α-dependent manner in pancreatic cancer cells.
    Hashimoto O; Shimizu K; Semba S; Chiba S; Ku Y; Yokozaki H; Hori Y
    Pathobiology; 2011; 78(4):181-92. PubMed ID: 21778785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.